Company
IndiaPublic company, NYSE: RDYDr. Reddy's Laboratories Ltd. (NYSE: RDY), Devunipalavalasa, India – FDA Inspections
Inspection records and compliance data for Dr. Reddy's Laboratories Ltd. in Devunipalavalasa. 3 FDA inspections on record, 1 Form 483, last inspected May 12, 2023. Publicly traded as NYSE: RDY.
Company Profile
This profile covers Dr. Reddy's Laboratories Ltd. based in Devunipalavalasa, India.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected May 12, 2017. Last inspected May 12, 2023.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 12, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1205163 |
| November 16, 2018 | Not classified | Human Drugs | 1076710 |
| May 12, 2017 | Not classified | Human Drugs | 1020965 |
FDA documents
Form 483s (2)
Other regulators (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Dr. Reddy's Laboratories Ltd.
Stock ticker
RDY
Exchange
NYSE
Share price
$14.73
Market cap
$12.3B
Price as of
November 13, 2026
FEI Number
3011171511
Address
71 - 73 Process Unit 02, Survey No 70; Ranasthalam Mandal, Devunipalavalasa, India
Country
India
ID: 769ee88d-49d7-4a19-b97a-63ec71cb7114